Atacicept Terminated Phase 2 Trials for Relapsing Multiple Sclerosis (RMS) Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00642902A Phase 2 Study of Atacicept in Subjects With Relapsing Multiple Sclerosis (ATAMS)
NCT00853762Atacicept in Multiple Sclerosis Extension Study, Phase II